- Home
- BPMC vs MSGS Comparison
BPMC vs MSGS Comparison
Compare BPMC & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- MSGS
- Stock Information
- Founded
- BPMC 2008
- MSGS 1879
- Country
- BPMC United States
- MSGS United States
- Employees
- BPMC N/A
- MSGS N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- MSGS Services-Misc. Amusement & Recreation
- Sector
- BPMC Health Care
- MSGS Consumer Discretionary
- Exchange
- BPMC Nasdaq
- MSGS Nasdaq
- Market Cap
- BPMC 5.9B
- MSGS 5.5B
- IPO Year
- BPMC 2015
- MSGS N/A
- Fundamental
- Price
- BPMC $90.14
- MSGS $225.35
- Analyst Decision
- BPMC Buy
- MSGS Buy
- Analyst Count
- BPMC 20
- MSGS 1
- Target Price
- BPMC $120.79
- MSGS $240.00
- AVG Volume (30 Days)
- BPMC 667.8K
- MSGS 76.7K
- Earning Date
- BPMC 02-13-2025
- MSGS 02-04-2025
- Dividend Yield
- BPMC N/A
- MSGS N/A
- EPS Growth
- BPMC N/A
- MSGS 57.82
- EPS
- BPMC N/A
- MSGS 2.91
- Revenue
- BPMC $434,415,000.00
- MSGS $1,037,410,000.00
- Revenue This Year
- BPMC $108.09
- MSGS N/A
- Revenue Next Year
- BPMC $39.34
- MSGS $8.60
- P/E Ratio
- BPMC N/A
- MSGS $77.33
- Revenue Growth
- BPMC 100.93
- MSGS 14.45
- 52 Week Low
- BPMC $72.24
- MSGS $176.27
- 52 Week High
- BPMC $121.90
- MSGS $237.99
- Technical
- Relative Strength Index (RSI)
- BPMC 42.11
- MSGS 45.44
- Support Level
- BPMC $86.02
- MSGS $222.75
- Resistance Level
- BPMC $98.41
- MSGS $237.99
- Average True Range (ATR)
- BPMC 3.28
- MSGS 4.30
- MACD
- BPMC -0.76
- MSGS -1.12
- Stochastic Oscillator
- BPMC 33.04
- MSGS 17.06
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.